+

Cookies on the Business Insider India website

Business Insider India has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings, we\'ll assume that you are happy to receive all cookies on the Business Insider India website. However, you can change your cookie setting at any time by clicking on our Cookie Policy at any time. You can also see our Privacy Policy.

Close
HomeQuizzoneWhatsappShare Flash Reads
 

The first approved COVID-19 drug is far from 'amazing'

Oct 26, 2020, 19:27 IST
Business Insider
Hollis Johnson/Business Insider

Welcome to Business Insider's daily healthcare newsletter, your daily dose of pharma, biotech, and healthcare news. Subscribe here to get this newsletter in your inbox every weekday.

Advertisement

Hello,

The coronavirus pandemic is overwhelming the US yet again, with the country recording its 2 worst-ever days of infection over the weekend.

"We are not going to control the pandemic," White House Chief of Staff Mark Meadows said Sunday on CNN.

Also in healthcare news: Gilead's set to make billions on a drug that's far from "amazing", AstraZeneca and Johnson & Johnson have restarted vaccine trials in the US, and universal masking could save 130,000.

Advertisement

Vials of the drug Remdesivir pictured during a press conference about the start of a study with the Ebola drug Remdesivir in particularly severely ill patients at the University Hospital Eppendorf (UKE) in Hamburg, northern Germany on April 8, 2020, amidst the new coronavirus COVID-19 pandemic.ULRICH PERREY/POOL/AFP via Getty Images

Gilead is set to sell billions of dollars of a coronavirus drug that's far from 'amazing' after the US approved remdesivir to treat COVID-19

Read the full story from Andrew Dunn here>>

Capped vials are being pictured during filling and packaging tests for the large-scale production and supply of the University of Oxfords COVID-19 vaccine candidate, AZD1222VINCENZO PINTO/AFP via Getty Images

AstraZeneca and Johnson & Johnson get FDA green light to resume coronavirus vaccine trials in the US after participants got sick

Read the full story from Allana Akhtar here>>

President Donald Trump.AP Photo/Alex Brandon

Universal mask-wearing could save 130,000 US lives before March, mitigating the worst of this 3rd coronavirus surge

Read the full story from Aria Bendix here>>

More stories we're reading:

Advertisement

Subscribe here for daily updates from the healthcare team!

- Lydia

You are subscribed to notifications!
Looks like you've blocked notifications!
Next Article